Name | Kif15-IN-1 |
---|---|
Synonyms |
5-Thiazolecarboxylic acid, 2-[[(2S)-2-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)-3-methyl-1-oxobutyl]amino]-4-methyl-, ethyl ester
Ethyl 2-{[(2S)-2-(2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-3-methylbutanoyl]amino}-4-methyl-1,3-thiazole-5-carboxylate |
Description | Kif15-IN-1 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. |
---|---|
Related Catalog | |
Target |
KIF15 |
In Vitro | Kif15-IN-1 (Compound 10) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C20H22N4O5S |
Molecular Weight | 430.478 |
Exact Mass | 430.131104 |
LogP | 3.73 |
Index of Refraction | 1.619 |
Storage condition | 2-8℃ |